JP2009256374A5 - - Google Patents

Download PDF

Info

Publication number
JP2009256374A5
JP2009256374A5 JP2009181759A JP2009181759A JP2009256374A5 JP 2009256374 A5 JP2009256374 A5 JP 2009256374A5 JP 2009181759 A JP2009181759 A JP 2009181759A JP 2009181759 A JP2009181759 A JP 2009181759A JP 2009256374 A5 JP2009256374 A5 JP 2009256374A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
stem cells
nitric oxide
oxide donor
formulation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009181759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009256374A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009256374A publication Critical patent/JP2009256374A/ja
Publication of JP2009256374A5 publication Critical patent/JP2009256374A5/ja
Pending legal-status Critical Current

Links

JP2009181759A 2002-01-04 2009-08-04 疾患および損傷の処置のための一酸化窒素ドナー Pending JP2009256374A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34547802P 2002-01-04 2002-01-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003557275A Division JP4545440B2 (ja) 2002-01-04 2003-01-06 疾患および損傷の処置のための一酸化窒素ドナー

Publications (2)

Publication Number Publication Date
JP2009256374A JP2009256374A (ja) 2009-11-05
JP2009256374A5 true JP2009256374A5 (enExample) 2010-09-16

Family

ID=23355218

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003557275A Expired - Fee Related JP4545440B2 (ja) 2002-01-04 2003-01-06 疾患および損傷の処置のための一酸化窒素ドナー
JP2009181759A Pending JP2009256374A (ja) 2002-01-04 2009-08-04 疾患および損傷の処置のための一酸化窒素ドナー

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003557275A Expired - Fee Related JP4545440B2 (ja) 2002-01-04 2003-01-06 疾患および損傷の処置のための一酸化窒素ドナー

Country Status (9)

Country Link
US (2) US20050143388A1 (enExample)
EP (1) EP1469852A4 (enExample)
JP (2) JP4545440B2 (enExample)
CN (1) CN1638775A (enExample)
AU (1) AU2003210447B2 (enExample)
CA (1) CA2471147C (enExample)
IL (1) IL162850A0 (enExample)
WO (1) WO2003056899A2 (enExample)
ZA (1) ZA200405507B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1909793A2 (de) * 2005-07-15 2008-04-16 Proxomed Medizintechnik GmbH Verwendung von phosphodiesterase typ 5-hemmern für die prävention und behandlung von erkrankungen oder gesundheitsstörungen, sowie abgabesysteme für dieselben
WO2008020864A2 (en) * 2005-11-14 2008-02-21 The Trustees Of Columbia University In The City Of New York Imaging correlates of neurogenesis with mri
US8841300B2 (en) 2006-10-02 2014-09-23 Jerry M. Held Treatment for Parkinson's disease—combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor
JP2010527928A (ja) * 2007-05-18 2010-08-19 ヴィヴァス・インコーポレイテッド ホスホジエステラーゼ−5阻害剤を含む新規の組み合わせおよびそれらの使用
US20110104100A1 (en) * 2007-10-04 2011-05-05 Medistem Laboratories, Inc. Compositions and methods of stem cell therapy for autism
WO2009059271A1 (en) * 2007-11-02 2009-05-07 University Of Miami Diagnosis and treatment of cardiac disorders
MX361539B (es) 2012-04-25 2018-12-10 Takeda Pharmaceuticals Co Compuesto heterociclico nitrogenado.
EP2873669A4 (en) 2012-07-13 2015-11-25 Takeda Pharmaceutical HETEROCYCLIC CONNECTION
JP6338601B2 (ja) * 2013-03-01 2018-06-06 フンダシオン パラ ラ インベスティガシオン メディカ アプリカダ ホスホジエステラーゼとヒストンデアセチラーゼの二重阻害剤としての新規な化合物
EP2975031A4 (en) 2013-03-14 2017-04-19 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2015002231A1 (ja) 2013-07-03 2015-01-08 武田薬品工業株式会社 複素環化合物
US10472376B2 (en) 2013-07-03 2019-11-12 Takeda Pharmaceutical Company Limited Amide compound
US10297661B2 (en) * 2017-06-30 2019-05-21 Taiwan Semiconductor Manufacturing Co., Ltd. High voltage resistor device
TWI879058B (zh) * 2023-08-31 2025-04-01 未來新藥股份有限公司 Pde5抑制劑組合於促進神經突生長之新穎用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2187086A1 (en) * 1994-04-15 1995-10-26 Masaomi Iyo A pharmaceutical composition for therapeutically treating tardive dyskinesia and uses therof
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
EP1006798A4 (en) * 1996-09-05 2003-03-05 Massachusetts Inst Technology COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES
US6043223A (en) * 1997-11-12 2000-03-28 The Regents Of The University Of California Enhanced opening of abnormal brain tissue capillaries
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
DK1183035T3 (en) 1999-05-14 2015-03-09 Ford Henry Health System BONE MARROW TRANSPLANT TREATMENT stroke
NZ516513A (en) * 1999-06-14 2004-03-26 Ford Henry Health System Nitric oxide donors for inducing neurogenesis
US6075028A (en) 1999-09-23 2000-06-13 Graham; Richard Method of treating Tourette's syndrome and related CNS disorders
IL139073A0 (en) * 1999-10-21 2001-11-25 Pfizer Treatment of neuropathy
US6271228B1 (en) * 2000-04-28 2001-08-07 Pfizer Inc. Blood pressure stabilization during hemodialysis
EP1355669B1 (en) * 2000-08-10 2011-09-28 Cold Spring Harbor Laboratory Augmented cognitive training

Similar Documents

Publication Publication Date Title
JP2009256374A5 (enExample)
JP2012255026A5 (enExample)
JP2010222367A5 (enExample)
JP2013542247A5 (enExample)
JP2010535814A5 (enExample)
JP2012500090A5 (enExample)
ECSP13012467A (es) Uso de aglutinantes para fabricar formulaciones estables al almacenamiento
JP2012530141A5 (enExample)
WO2010062688A3 (en) Dosage form for insertion into the mouth
HRP20240168T1 (hr) Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
NZ605469A (en) Nalbuphine-based formulations and uses thereof
AR061166A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilferina
RU2014142025A (ru) Препарат длительного высвобождения для снижения частоты мочеиспускания и способ его применения
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
MA32406B1 (fr) Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens
JP2012508256A5 (enExample)
JP2007238598A5 (enExample)
DK1746980T3 (da) Farmaceutisk doseringsform omfattende pellets såvel som deres fremstillingsfremgangsmåde
JP2018039810A5 (enExample)
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen
JP2002537232A5 (enExample)
JP2011516572A5 (enExample)
JP2006342148A5 (enExample)